Autism Life Expectancy Gap Study
Analysis based on 8 articles · First reported Sep 10, 2026 · Last updated Sep 16, 2026
This study is unlikely to have a direct material impact on financial markets, as it primarily concerns public health and social policy. However, it may influence future healthcare spending and insurance policies related to autism care, with potential long-term implications for United States — Medicaid budgets and private insurers.
A study published in JAMA Network Open by researchers at Columbia University and the University of Colorado found that United States — Medicaid beneficiaries with autism spectrum disorder have a life expectancy of 64.9 years, 13.8 years shorter than the general United States population and 5.6 years shorter than the overall United States — Medicaid population. The study analyzed 21 years of United States — Medicaid data linked to the United States — National Death Index, covering over 2 million individuals with autism from 2000 to 2020. Excess mortality was driven by preventable conditions such as influenza, malnutrition, pneumonitis, drowning, and pneumonia. The research was funded by the United States — National Institutes of Health. Experts including David Mandell of the University of Pennsylvania commented on the findings, noting the gap is similar to that seen in schizophrenia and emphasizing the need for improved primary care and support services. The study highlights significant health inequities and calls for targeted interventions to reduce preventable deaths among autistic individuals.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard